Ultrasound Guided Posterior Sacroiliac Ligament Corticosteroid Injection in Pregnancy-Related Pelvic Girdle Pain

NCT02044991 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2018-08-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if pelvic girdle pain can be more effectively treated with the use of injectable anti-inflammatory medication plus physical therapy compared with physical therapy and a saline injection.

Conditions

  • Pelvic Girdle Pain

Interventions

DRUG

Corticosteroid

40mg of a non-fluorinated injectable glucocorticoid, methylprednisolone acetate (1cc) combined with 1cc of 1% Lidocaine

DRUG

Placebo Injection

A placebo injection

Sponsors & Collaborators

  • American Academy of Physical Medicine and Rehabilitation

    collaborator OTHER
  • Loyola University

    lead OTHER

Principal Investigators

  • Colleen Fitzgerald, MD · Loyola Univ Med Cntr-

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-24
Primary Completion
2017-02-22
Completion
2017-02-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02044991 on ClinicalTrials.gov